Press release
Hereditary Angioedema Market Report Outlook till 2027 - BIOCRYST PHARMACEUTICALS, INC, CSL Ionis Pharmaceuticals, Inc., Merck Sharp & Dohme Corp, Pharming Group N. V.
This market research report provides a comprehensive picture on “Hereditary Angioedema Market”, from the global viewpoint, offering a forecast and statistic in terms of revenue during the forecast period.The report covers a descriptive analysis with detailed segmentation, complete research and development history, latest news and press releases. Furthermore, the study explains the future opportunities and a sketch of key players operating in the “Hereditary Angioedem Market”.
Hereditary Angioedema is a rare disorder characterized by recurrent episodes of severe swelling in body parts like limbs, face, intestinal tract or airway. Minor trauma or stress may trigger an attack but swelling often occurs without a known trigger.
Get Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00005410/?utm_source=OpenPR&utm_medium=Sumaiya
The Hereditary Angioedema market is anticipated to grow in the forecast, owing to the factors such as rise in hereditary angioedema attacks, increasing R&D initiatives by the manufacturers, presence of promising drug pipeline, and approval of novel therapies by the regulatory agencies. Nevertheless, lack of awareness regarding the disease, and high cost of the drugs are expected to restrict the market growth during the forecast period.
Key players:
- BIOCRYST PHARMACEUTICALS, INC
- CSL
- Ionis Pharmaceuticals, Inc.
- Merck Sharp & Dohme Corp
- Pharming Group N. V.
- Sanofi N. V.
- Shire plc.
- Teva Pharmaceutical Industries, Ltd.
- Attune Pharmaceuticals
- KalVista Pharmaceuticals, Inc
Detailed segmentation of the market, on the basis of Drugs, Route of Administration, Distribution Channel and a descriptive structure of trends of the segments and sub-segments are elaborated in the report. It also provides the market size and estimates a forecast from the year 2018 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The report also provides exhaustive PEST analysis for all five regions after evaluating political, economic, social and technological factors effecting the Hereditary Angioedema market.
Key Reasons:
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Hereditary Angioedema market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global Hereditary Angioedema market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Buy Complete Report at https://www.theinsightpartners.com/buy/TIPRE00005410/?utm_source=OpenPR&utm_medium=Sumaiya
About us: –
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Contact us: –
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hereditary Angioedema Market Report Outlook till 2027 - BIOCRYST PHARMACEUTICALS, INC, CSL Ionis Pharmaceuticals, Inc., Merck Sharp & Dohme Corp, Pharming Group N. V. here
News-ID: 1876693 • Views: …
More Releases from The Insight Partners
Insect Pest Control - Obtain PDF Sample Copy
The Insect Pest Control Market size is projected to reach US$ 14.85 billion by 2031 from US$ 21.33 billion in 2024. The market is expected to register a CAGR of 5.4% during 2025-2031. The proactive health measures, combined with heightened consumer awareness about disease prevention, have boosted the demand for both professional pest control services and DIY products. The convergence of public health policies, regulatory vigilance, and increased risk perception…
Denim Fabrics - Obtain PDF Sample Copy
The denim fabrics market size is projected to reach US$ 28.69 billion by 2031 from US$ 22.32 billion in 2024. The market is expected to register a CAGR of 3.8% during 2025-2031. The denim fabrics market is growing steadily owing to changing consumer preferences, fashion trends, and increasing accessibility. Denim has evolved from being a utilitarian fabric to a mainstream fashion item, appreciated for its flexibility, comfort, and ease. With…
Photomedicine Devices and Technologies Market Global Rising Demand & Huge Scope …
A new market study report by The Insight Partners on the Photomedicine Devices and Technologies Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period.
Get PDF Sample…
Genetic Testing Services Market Global Rising Demand & Huge Scope Till 2031
Genetic Testing Services Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market…
More Releases for Hereditary
Hereditary Angioedema Market: An In-Depth Analysis
In 2024, the market for Hereditary Angioedema Market was valued at USD 3.1 billion. It is anticipated to grow to USD 5.9 billion by 2033, with a CAGR of 6.82% over the period 2026-2033.
Hereditary Angioedema Market Overview
The global hereditary angioedema therapeutics market is experiencing significant expansion, driven by increasing awareness, improved diagnostic capabilities, and the introduction of novel treatment options. Advances in genetic research have enabled early and accurate…
Leber Hereditary Optic Neuropathy Treatment Market
Introduction
Leber Hereditary Optic Neuropathy (LHON) is a genetic condition that leads to severe vision loss, primarily affecting young adults. This disorder is caused by mutations in mitochondrial DNA, which impairs the function of retinal ganglion cells. As awareness of LHON has grown, so too has the focus on its treatment options. The LHON treatment market is evolving rapidly, driven by advancements in genetic therapies, pharmaceuticals, and supportive care strategies. This…
Hereditary Hemochromatosis Market - Redefining Care, Inspiring Hope: Hereditary …
Newark, New Castle, USA: The "Hereditary Hemochromatosis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Hereditary Hemochromatosis Market: https://www.growthplusreports.com/report/hereditary-hemochromatosis-market/8793
This latest report researches the industry structure, sales, revenue,…
Hereditary Angioedema Market Research Report 2032
DelveInsight's "Hereditary Angioedema Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the Hereditary Angioedema, historical and forecasted epidemiology as well as the Hereditary Angioedema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Hereditary Angioedema (HAE) is a rare genetic disorder caused by the deficiency in functional C1 inhibitor (C1INH) that results in recurrent attacks of localized subcutaneous or…
Hereditary Angioedema - Drug Pipeline Landscape, 2022
Global Hereditary Angioedema Market report from Global Insight Services is the single authoritative source of intelligence on hereditary angioedema market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,…
Hereditary Angioedema - Drug Pipeline Landscape, 2022
Hereditary Angioedema is an infrequent inherited disease that causes substantial swelling in various body tissues, such as the abdomen or face caused by a low level or improper function of a protein called the C1 inhibitor. There are three types of hereditary angioedema namely type I, II, and III.
Hereditary Angioedema is mainly caused by a low level or improper function of a protein called the C1 inhibitor.
Read more about Hereditary…
